{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:47Z","timestamp":1791216587150,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11904-021-00564-z","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T12:04:17Z","timestamp":1622981057000},"page":"280-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management"],"prefix":"10.1007","volume":"18","author":[{"given":"Melody","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dashwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-5692","authenticated-orcid":false,"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,6]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","unstructured":"French, Patrick. \u201cSyphilis.\u201d BMJ, 2007, doi:https:\/\/doi.org\/10.1136\/bmj.39085.518148.BE, Syphilis.","DOI":"10.1136\/bmj.39085.518148.BE"},{"issue":"1","key":"564_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1086\/315209","volume":"181","author":"TJ Sellati","year":"2000","unstructured":"Sellati TJ, et al. Virulent Treponema Pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. The Journal of Infectious Diseases. 2000;181(1):283\u201393. https:\/\/doi.org\/10.1086\/315209.","journal-title":"The Journal of Infectious Diseases"},{"issue":"15","key":"564_CR3","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1097\/00002030-200410210-00012","volume":"18","author":"K Buchacz","year":"2004","unstructured":"Buchacz K, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004;18(15):2075\u20139. https:\/\/doi.org\/10.1097\/00002030-200410210-00012.","journal-title":"AIDS"},{"issue":"3","key":"564_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/01.olq.0000187262.56820.c0","volume":"33","author":"K Kofoed","year":"2006","unstructured":"Kofoed K, et al. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sexually Transmitted Diseases. 2006;33(3):143\u20138. https:\/\/doi.org\/10.1097\/01.olq.0000187262.56820.c0.","journal-title":"Sexually Transmitted Diseases"},{"issue":"7","key":"564_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/s1473-3099(04)01061-8","volume":"4","author":"WA Lynn","year":"2004","unstructured":"Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. The Lancet Infectious Diseases. 2004;4(7):456\u201366. https:\/\/doi.org\/10.1016\/s1473-3099(04)01061-8.","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"564_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/01.smj.0000121204.58881.60","volume":"97","author":"G Smith","year":"2004","unstructured":"Smith G, Holman RP. The prozone phenomenon with syphilis and HIV-1 co-infection. Southern Medical Journal. 2004;97(4):379\u201382. https:\/\/doi.org\/10.1097\/01.smj.0000121204.58881.60.","journal-title":"Southern Medical Journal"},{"issue":"11","key":"564_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1258\/095646205774763207","volume":"16","author":"A Geusau","year":"2005","unstructured":"Geusau A, et al. Biological false-positive tests comprise a high proportion of venereal disease research laboratory reactions in an analysis of 300,000 sera. International Journal of STD & AIDS. 2005;16(11):722\u20136. https:\/\/doi.org\/10.1258\/095646205774763207.","journal-title":"International Journal of STD & AIDS"},{"issue":"5","key":"564_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/nejm199707313370504","volume":"337","author":"RT Rolfs","year":"1997","unstructured":"Rolfs RT, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. New England Journal of Medicine. 1997;337(5):307\u201314. https:\/\/doi.org\/10.1056\/nejm199707313370504.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"564_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/sti.2006.021402","volume":"83","author":"KG Ghanem","year":"2006","unstructured":"Ghanem KG, et al. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sexually Transmitted Infections. 2006;83(2):97\u2013101. https:\/\/doi.org\/10.1136\/sti.2006.021402.","journal-title":"Sexually Transmitted Infections"},{"issue":"1","key":"564_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0002-9343(99)80105-3","volume":"99","author":"JL Malone","year":"1995","unstructured":"Malone JL, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. The American Journal of Medicine. 1995;99(1):55\u201363. https:\/\/doi.org\/10.1016\/s0002-9343(99)80105-3.","journal-title":"The American Journal of Medicine"},{"issue":"7","key":"564_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00007435-200008000-00002","volume":"27","author":"A Pettifor","year":"2000","unstructured":"Pettifor A, et al. How effective is syndromic management of STDs? Sexually Transmitted Diseases. 2000;27(7):371\u201385. https:\/\/doi.org\/10.1097\/00007435-200008000-00002.","journal-title":"Sexually Transmitted Diseases"},{"issue":"1","key":"564_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.srhc.2010.08.006","volume":"2","author":"LF Johnson","year":"2011","unstructured":"Johnson LF, et al. The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sexual & Reproductive Healthcare. 2011;2(1):13\u201320. https:\/\/doi.org\/10.1016\/j.srhc.2010.08.006.","journal-title":"Sexual & Reproductive Healthcare"},{"issue":"5","key":"564_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00007435-200305000-00008","volume":"30","author":"HW Chesson","year":"2003","unstructured":"Chesson HW, et al. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sexually Transmitted Diseases. 2003;30(5):419\u201324. https:\/\/doi.org\/10.1097\/00007435-200305000-00008.","journal-title":"Sexually Transmitted Diseases"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijid.2014.05.014","volume":"29","author":"CR Kenyon","year":"2014","unstructured":"Kenyon CR, et al. What underpins the decline in syphilis in Southern and Eastern Africa? An Exploratory Ecological Analysis. International Journal of Infectious Diseases. 2014;29:54\u201361. https:\/\/doi.org\/10.1016\/j.ijid.2014.05.014.","journal-title":"International Journal of Infectious Diseases"},{"key":"564_CR15","doi-asserted-by":"publisher","unstructured":"Abara WE, et al. Syphilis trends among men who have sex with men in the United States and Western Europe: a systematic review of trend studies published between 2004 and 2015. PLOS ONE. 2016;11(7). https:\/\/doi.org\/10.1371\/journal.pone.0159309.","DOI":"10.1371\/journal.pone.0159309"},{"key":"564_CR16","unstructured":"European Centre for Disease Prevention and Control. \u201cSyphilis. In: ECDC. Annual epidemiological report for 2018.\u201d Stockholm: ECDC; 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/syphilis-aer-2018.pdf"},{"key":"564_CR17","unstructured":"Australian Government Department of Health. \u201cThird national sexually transmissible infections strategy 2014\u20132017. \u201c 2014. Australian Government Department of Health.https:\/\/consultations.health.gov.au\/ohpd-health-protection-policy-branch\/test-national-strategies-for-blood-borne-viruses-a\/supporting_documents\/Draft%203rd%20National%20STI%20Strategy%2020142017%20D14818806.PDF"},{"key":"564_CR18","unstructured":"Australian Government Department of Health. \u201cThe health of Australia\u2019s males, sexual health.\u201d Australian Institute of Health and Welfare, (n.d.) www.aihw.gov.au\/reports\/men-women\/male-health\/contents\/how-healthy\/sexual-health."},{"issue":"2","key":"564_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0956462416638224","volume":"28","author":"G Chen","year":"2016","unstructured":"Chen G, et al. Syphilis incidence among men who have sex with men in China: results from a meta-analysis. International Journal of STD & AIDS. 2016;28(2):170\u20138. https:\/\/doi.org\/10.1177\/0956462416638224.","journal-title":"International Journal of STD & AIDS"},{"key":"564_CR20","unstructured":"Centers for Disease Control and Prevention. \u201c2018 sexually transmitted diseases surveillance: syphilis.\u201d Atlanta, GA: Centers for Disease Control and Prevention; 2019, Available at https:\/\/www.cdc.gov\/std\/stats18\/syphilis.htm"},{"key":"564_CR21","unstructured":"Public Health Agency of Canada. \u2018Government of Canada.\u2019. \u201cCCDR: Volume 45 \u2013 11 \u2013 November 7, 2019: sexually trans- mitted infections in men who have sex with men \u2013 Canada.\u201d Ottawa, Canada: Public Health Agency of Canada. Government of Canada; 2019, Available at www.canada.ca\/en\/public- health\/services\/reports-publications\/canada-communicable- disease-report-ccdr\/monthly-issue\/2019-45\/issue-11-novem- ber-7-2019.html|"},{"key":"564_CR22","doi-asserted-by":"publisher","unstructured":"Wong NS, et al. Distribution of reported syphilis cases in South China: spatiotemporal analysis. Scientific Reports. 2018;8(1). https:\/\/doi.org\/10.1038\/s41598-018-27173-y.","DOI":"10.1038\/s41598-018-27173-y"},{"issue":"7","key":"564_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/s1473-3099(17)30227-x","volume":"17","author":"S Yang","year":"2017","unstructured":"Yang S, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. The Lancet Infectious Diseases. 2017;17(7):716\u201325. https:\/\/doi.org\/10.1016\/s1473-3099(17)30227-x.","journal-title":"The Lancet Infectious Diseases"},{"issue":"21","key":"564_CR24","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1001\/jama.2016.5824","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, et al. Screening for syphilis infection in nonpregnant adults and adolescents. JAMA. 2016;315(21):2321. https:\/\/doi.org\/10.1001\/jama.2016.5824.","journal-title":"JAMA"},{"issue":"2","key":"564_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/nejmp048126","volume":"351","author":"EW Hook","year":"2004","unstructured":"Hook EW, Peeling RW. Syphilis control \u2014 a continuing challenge. New England Journal of Medicine. 2004;351(2):122\u20134. https:\/\/doi.org\/10.1056\/nejmp048126.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"564_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s40471-018-0138-z","volume":"5","author":"N Kojima","year":"2018","unstructured":"Kojima N, Klausner JD. An update on the global epidemiology of syphilis. Current Epidemiology Reports. 2018;5(1):24\u201338. https:\/\/doi.org\/10.1007\/s40471-018-0138-z.","journal-title":"Current Epidemiology Reports"},{"key":"564_CR27","unstructured":"World Health Organization. Global Health Observatory data repository. 2017. Available at: http:\/\/apps.who.int.myaccess.library.utoronto.ca\/gho\/data\/node.main.A1357STI?lang=en."},{"issue":"14","key":"564_CR28","first-page":"413","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. Congenital syphilis\u2014United States, 2003\u20132008. MMWR Morb Mortal Wkly Rep. 2010;59(14):413\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"564_CR29","first-page":"402","volume":"63","author":"ME Patton","year":"2014","unstructured":"Patton ME, et al. Primary and secondary syphilis\u2014United States, 2005\u20132013. MMWR Morb Mortal Wkly Rep. 2014;63(18):402\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"564_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14760584.2016.1203262","volume":"16","author":"KV Lithgow","year":"2016","unstructured":"Lithgow KV, Cameron CE. Vaccine development for syphilis. Expert Review of Vaccines. 2016;16(1):37\u201344. https:\/\/doi.org\/10.1080\/14760584.2016.1203262.","journal-title":"Expert Review of Vaccines"},{"key":"564_CR31","doi-asserted-by":"publisher","unstructured":"Newman L, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Medicine. 2013;10(2). https:\/\/doi.org\/10.1371\/journal.pmed.1001396.","DOI":"10.1371\/journal.pmed.1001396"},{"key":"564_CR32","doi-asserted-by":"publisher","unstructured":"Ishikawa N, et al. Elimination of mother-to-child transmission of hiv and syphilis in Cuba and Thailand. Bulletin of the World Health Organization. 2016;94(11). https:\/\/doi.org\/10.2471\/blt.16.185033.","DOI":"10.2471\/blt.16.185033"},{"key":"564_CR33","unstructured":"\u201cWHO Validation for the Elimination of Mother-to-Child Transmission of HIV and\/or Syphilis.\u201d World Health Organization, World Health Organization, 2 Apr. 2020, www.who.int\/reproductivehealth\/congenital-syphilis\/WHO-validation-EMTCT\/en\/."},{"key":"564_CR34","doi-asserted-by":"publisher","unstructured":"Kenyon CR, et al. The global epidemiology of syphilis in the past century \u2013 a systematic review based on antenatal syphilis prevalence. PLOS Neglected Tropical Diseases. 2016;10(5). https:\/\/doi.org\/10.1371\/journal.pntd.0004711.","DOI":"10.1371\/journal.pntd.0004711"},{"key":"564_CR35","doi-asserted-by":"publisher","unstructured":"Kenyon CR, et al. Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium \u2013 1992 to 2012. Eurosurveillance. 2014;19(45). https:\/\/doi.org\/10.2807\/1560-7917.es2014.19.45.20958.","DOI":"10.2807\/1560-7917.es2014.19.45.20958"},{"issue":"21","key":"564_CR36","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.2016.7073","volume":"315","author":"ME Clement","year":"2016","unstructured":"Clement ME, Hicks CB. Syphilis on the rise. JAMA. 2016;315(21):2281\u20133. https:\/\/doi.org\/10.1001\/jama.2016.7073.","journal-title":"JAMA"},{"key":"564_CR37","doi-asserted-by":"publisher","unstructured":"Mayor S. Syphilis and Gonorrhoea increase sharply in England. BMJ. 2015;350, no. jun25 12. https:\/\/doi.org\/10.1136\/bmj.h3457.","DOI":"10.1136\/bmj.h3457"},{"issue":"14","key":"564_CR38","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/qad.0000000000001185","volume":"30","author":"N Kojima","year":"2016","unstructured":"Kojima N, et al. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251\u20132. https:\/\/doi.org\/10.1097\/qad.0000000000001185.","journal-title":"AIDS"},{"issue":"1","key":"564_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","volume":"176","author":"AY Liu","year":"2016","unstructured":"Liu AY, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Internal Medicine. 2016;176(1):75. https:\/\/doi.org\/10.1001\/jamainternmed.2015.4683.","journal-title":"JAMA Internal Medicine"},{"issue":"10","key":"564_CR40","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","volume":"61","author":"JE Volk","year":"2015","unstructured":"Volk JE, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical Infectious Diseases. 2015;61(10):1601\u20133. https:\/\/doi.org\/10.1093\/cid\/civ778.","journal-title":"Clinical Infectious Diseases"},{"key":"564_CR41","unstructured":"La Fata L, et al. High asymptomatic STI prevalence and incidence in French MSM starting PrEP. San Diego: IDWeek. 2017;2017."},{"issue":"12","key":"564_CR42","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/qad.0000000000001519","volume":"31","author":"L Lal","year":"2017","unstructured":"Lal L, et al. Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users. AIDS. 2017;31(12):1709\u201314. https:\/\/doi.org\/10.1097\/qad.0000000000001519.","journal-title":"AIDS"},{"key":"564_CR43","doi-asserted-by":"publisher","unstructured":"Scott HM, Klausner JD. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Research and Therapy. 2016;13(1). https:\/\/doi.org\/10.1186\/s12981-016-0089-8.","DOI":"10.1186\/s12981-016-0089-8"},{"issue":"14","key":"564_CR44","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jama.2019.2947","volume":"321","author":"MW Traeger","year":"2019","unstructured":"Traeger MW, et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA. 2019;321(14):1380. https:\/\/doi.org\/10.1001\/jama.2019.2947.","journal-title":"JAMA"},{"issue":"3","key":"564_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10461-009-9524-3","volume":"13","author":"BR Simon Rosser","year":"2009","unstructured":"Simon Rosser BR, Oakes JM, Horvath KJ, Konstan JA, Danilenko GP, Peterson JL. HIV sexual risk behavior by men who use the internet to seek sex with men: results of the Men\u2019s INTernet Sex Study-II (MINTS-II). AIDS and Behavior. 2009;13(3):488\u201398. https:\/\/doi.org\/10.1007\/s10461-009-9524-3.","journal-title":"AIDS and Behavior"},{"key":"564_CR46","doi-asserted-by":"publisher","unstructured":"Gulland A. Number of cases of syphilis continue to rise: BMJ; 2017. https:\/\/doi.org\/10.1136\/bmj.j2807.","DOI":"10.1136\/bmj.j2807"},{"key":"564_CR47","doi-asserted-by":"publisher","unstructured":"McCarthy M. Syphilis rate rises in the US. BMJ. 2014;349, no. dec19(9). https:\/\/doi.org\/10.1136\/bmj.g7756.","DOI":"10.1136\/bmj.g7756"},{"issue":"9","key":"564_CR48","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/jama.1985.03350330094030","volume":"253","author":"ST Brown","year":"1985","unstructured":"Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment. A new analysis of old data. JAMA. 1985;253(9):1296\u20139.","journal-title":"JAMA"},{"key":"564_CR49","unstructured":"Public Health Agency of Canada. \u201cSyphilis \u2013 Section 5 \u2013 Management and treatment of specific infections \u2013 Canadian guide- lines on sexually transmitted infections.\u201d Ottawa, Canada: Public Health Agency of Canada; 2016, Available at http:\/\/www.phac- aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/section-5-10-eng.php"},{"key":"564_CR50","unstructured":"Centers for Disease Control and Prevention. \u201cSyphilis.\u201d Atlanta, GA: Centers for Disease Control and Prevention; 2016, Avail- able at www.cdc.gov\/std\/tg2015\/syphilis.htm"},{"key":"564_CR51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","volume":"35","author":"M Janier","year":"2020","unstructured":"Janier M, Unemo M, Dupin N, Tiplica GS, Poto\u010dnik M, Patel R. 2020 European guideline on the management of syphilis. Journal of the European Academy of Dermatology and Venereology. 2020;35:574\u201388. https:\/\/doi.org\/10.1111\/jdv.16946.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"564_CR52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/0956462415624059","volume":"27","author":"M Kingston","year":"2015","unstructured":"Kingston M, French P, Higgins S, McQuillan O, Sukthankar A, Stott C, et al. UK National Guidelines on the Management of Syphilis 2015. International Journal of STD & AIDS. 2015;27(6):421\u201346. https:\/\/doi.org\/10.1177\/0956462415624059.","journal-title":"International Journal of STD & AIDS"},{"key":"564_CR53","unstructured":"WHO guidelines for the treatment of Treponema pallidum (syphilis) \u2013 2016, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/249572\/9789241549806-eng.pdf;jsessionid=513ECEDA51D97FC0FCD7DECC8E7CA783?sequence=1."},{"key":"564_CR54","unstructured":"WHO guidelines for the management of sexually transmitted infections \u2013 2004, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42782\/9241546263_eng.pdf?sequence=1"},{"issue":"9","key":"564_CR55","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1086\/513427","volume":"44","author":"NM Zetola","year":"2007","unstructured":"Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clinical Infectious Diseases. 2007;44(9):1222\u20138. https:\/\/doi.org\/10.1086\/513427.","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"564_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.clindermatol.2010.03.012","volume":"28","author":"D Farhi","year":"2010","unstructured":"Farhi D, Dupin N. Management of syphilis in the HIV-infected patient: facts and controversies. Clinics in Dermatology. 2010;28(5):539\u201345. https:\/\/doi.org\/10.1016\/j.clindermatol.2010.03.012.","journal-title":"Clinics in Dermatology"},{"issue":"14","key":"564_CR57","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/qad.0000000000002656","volume":"34","author":"M Ren","year":"2020","unstructured":"Ren M, et al. Deciphering the Serological Response to Syphilis Treatment in Men Living with HIV. AIDS. 2020;34(14):2089\u201396. https:\/\/doi.org\/10.1097\/qad.0000000000002656.","journal-title":"AIDS"},{"key":"564_CR58","doi-asserted-by":"publisher","unstructured":"Nurse-Findlay S, et al. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews. PLOS Medicine. 2017;14(12). https:\/\/doi.org\/10.1371\/journal.pmed.1002473.","DOI":"10.1371\/journal.pmed.1002473"},{"key":"564_CR59","doi-asserted-by":"publisher","unstructured":"Ueleres BJ, et al. The shortage of benzathine penicillin and its impact on congenital syphilis incidence: an ecologic study in the City of Rio De Janeiro: Clinical Infectious Diseases; 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1716.","DOI":"10.1093\/cid\/ciaa1716"},{"issue":"3","key":"564_CR60","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1128\/aac.44.3.806-807.2000","volume":"44","author":"LV Stamm","year":"2000","unstructured":"Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23S RRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrobial Agents and Chemotherapy. 2000;44(3):806\u20137. https:\/\/doi.org\/10.1128\/aac.44.3.806-807.2000.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"564_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/qco.0b013e3282f44772","volume":"21","author":"KA Katz","year":"2008","unstructured":"Katz KA, Klausner JD. Azithromycin resistance in Treponema Pallidum. Current Opinion in Infectious Diseases. 2008;21(1):83\u201391. https:\/\/doi.org\/10.1097\/qco.0b013e3282f44772.","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"8","key":"564_CR62","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1017\/s0950268814002830","volume":"143","author":"LV Stamm","year":"2014","unstructured":"Stamm LV. Syphilis: antibiotic treatment and resistance. Epidemiology and Infection. 2014;143(8):1567\u201374. https:\/\/doi.org\/10.1017\/s0950268814002830.","journal-title":"Epidemiology and Infection"},{"issue":"2","key":"564_CR63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/aac.01095-09","volume":"54","author":"LV Stamm","year":"2009","unstructured":"Stamm LV. Global challenge of antibiotic-resistant Treponema Pallidum. Antimicrobial Agents and Chemotherapy. 2009;54(2):583\u20139. https:\/\/doi.org\/10.1128\/aac.01095-09.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"564_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/nejmoa040216","volume":"351","author":"SA Lukehart","year":"2004","unstructured":"Lukehart SA, et al. Macrolide resistance in Treponema Pallidumin the United States and Ireland. New England Journal of Medicine. 2004;351(2):154\u20138. https:\/\/doi.org\/10.1056\/nejmoa040216.","journal-title":"New England Journal of Medicine"},{"key":"564_CR65","doi-asserted-by":"publisher","unstructured":"Beale MA, et al. Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineages. Nature Communications. 2019;10(1). https:\/\/doi.org\/10.1038\/s41467-019-11216-7.","DOI":"10.1038\/s41467-019-11216-7"},{"issue":"10","key":"564_CR66","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/OLQ.0b013e31826f36de","volume":"39","author":"A2058G Prevalence Workgroup","year":"2012","unstructured":"A2058G Prevalence Workgroup. Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in Treponema pallidum in the United States, 2007 to 2009. Sex Transm Dis. 2012;39(10):794\u20138. https:\/\/doi.org\/10.1097\/OLQ.0b013e31826f36de.","journal-title":"Sex Transm Dis"},{"issue":"10","key":"564_CR67","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/1469-0691.12098","volume":"19","author":"X-S Chen","year":"2013","unstructured":"Chen X-S, Yin YP, Wei WH, Wang HC, Peng RR, Zheng HP, et al. High prevalence of azithromycin resistance to Treponema Pallidum in geographically different areas in China. Clinical Microbiology and Infection. 2013;19(10):975\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12098.","journal-title":"Clinical Microbiology and Infection"},{"key":"564_CR68","unstructured":"Centers for Disease Control and Prevention. \u201cProcaine penicillin G shortage.\u201d 2017. Available at: https:\/\/www-cdc-gov.myaccess.library.utoronto.ca\/std\/treatment\/drugnotices\/procaine-peng.htm.)"},{"issue":"9","key":"564_CR69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.15698\/mic2016.09.523","volume":"3","author":"LV Stamm","year":"2016","unstructured":"Stamm LV. Syphilis: re-emergence of an old foe. Microbial Cell. 2016;3(9):363\u201370. https:\/\/doi.org\/10.15698\/mic2016.09.523.","journal-title":"Microbial Cell"},{"issue":"11","key":"564_CR70","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/cid\/ciaa880","volume":"71","author":"K Sigel","year":"2020","unstructured":"Sigel K, et al. Coronavirus 2019 and people living with human immunodeficiency virus: outcomes for hospitalized patients in New York City. Clinical Infectious Diseases. 2020;71(11):2933\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa880.","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"564_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/qai.0000000000002423","volume":"85","author":"S Karmen-Tuohy","year":"2020","unstructured":"Karmen-Tuohy S, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;85(1):6\u201310. https:\/\/doi.org\/10.1097\/qai.0000000000002423.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"564_CR72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/apc.2020.0092","volume":"34","author":"W Lodge","year":"2020","unstructured":"Lodge W, Kuchukhidze S. COVID-19, HIV, and migrant workers: the double burden of the two viruses. AIDS Patient Care and STDs. 2020;34(6):249\u201350. https:\/\/doi.org\/10.1089\/apc.2020.0092.","journal-title":"AIDS Patient Care and STDs"},{"key":"564_CR73","doi-asserted-by":"publisher","unstructured":"Jiang H, et al. Maintaining HIV care during the COVID-19 pandemic. The Lancet HIV. 2020;7(5). https:\/\/doi.org\/10.1016\/s2352-3018(20)30105-3.","DOI":"10.1016\/s2352-3018(20)30105-3"},{"key":"564_CR74","doi-asserted-by":"publisher","unstructured":"Hogan AB, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. The Lancet Global Health. 2020;8(9). https:\/\/doi.org\/10.1016\/s2214-109x(20)30288-6.","DOI":"10.1016\/s2214-109x(20)30288-6"},{"key":"564_CR75","doi-asserted-by":"publisher","unstructured":"Jewell BL, et al. Potential effects of disruption to HIV programmes in Sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. The Lancet HIV. 2020;7(9). https:\/\/doi.org\/10.1016\/s2352-3018(20)30211-3.","DOI":"10.1016\/s2352-3018(20)30211-3"},{"issue":"1","key":"564_CR76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/sextrans-2020-054543","volume":"97","author":"A Latini","year":"2020","unstructured":"Latini A, et al. Is COVID-19 affecting the epidemiology of STIs? The experience of syphilis in Rome. Sexually Transmitted Infections. 2020;97(1):78. https:\/\/doi.org\/10.1136\/sextrans-2020-054543.","journal-title":"Sexually Transmitted Infections"},{"key":"564_CR77","doi-asserted-by":"publisher","unstructured":"Chia, Chun-Chieh, et al. \u201cDiagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan.\u201d Sexually Transmitted Infections, 2020, doi:https:\/\/doi.org\/10.1136\/sextrans-2020-054802","DOI":"10.1136\/sextrans-2020-054802"},{"key":"564_CR78","doi-asserted-by":"publisher","unstructured":"De Miguel Buckley R, et al. Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. Journal of Travel Medicine. 2020;27(8). https:\/\/doi.org\/10.1093\/jtm\/taaa134.","DOI":"10.1093\/jtm\/taaa134"},{"key":"564_CR79","unstructured":"Public Health Ontario. \u201cMonthly infectious disease surveillance report\u201d (n.d.) https:\/\/www.publichealthontario.ca\/-\/media\/documents\/surveillance-reports\/infectious\/surveillance-report-infectious-diseases-2020.pdf?la=en"},{"key":"564_CR80","doi-asserted-by":"publisher","unstructured":"Jenness SM, et al. Projected HIV and bacterial STI incidence following COVID-related sexual distancing and clinical service interruption. The Journal of Infectious Diseases. 2021. https:\/\/doi.org\/10.1093\/infdis\/jiab051.","DOI":"10.1093\/infdis\/jiab051"},{"key":"564_CR81","unstructured":"Public Health Agency of Canada. \u201cReport on sexually transmitted infections in Canada, 2017\u201d https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/report-sexually-transmitted-infections-canada-2017.html#a6"},{"issue":"3","key":"564_CR82","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00007435-200103000-00007","volume":"28","author":"AM Rompalo","year":"2001","unstructured":"Rompalo AM, et al. Clinical manifestations of early syphilis by HIV status and gender. Sex Transm Dis. 2001;28(3):158\u201365. https:\/\/doi.org\/10.1097\/00007435-200103000-00007.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"564_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ddmec.2007.12.003","volume":"4","author":"A Rebbapragada","year":"2007","unstructured":"Rebbapragada A, Kaul R. More than their sum in your parts: the mechanisms that underpin the mutually advantageous relationship between HIV and sexually transmitted infections. Drug Discovery Today: Disease Mechanisms. 2007;4(4):237\u201346. https:\/\/doi.org\/10.1016\/j.ddmec.2007.12.003.","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"key":"564_CR84","doi-asserted-by":"publisher","unstructured":"Burchell AN, et al. Enhanced Syphilis Screening among HIV-Positive Men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design. Implementation Science. 2015;11(1). https:\/\/doi.org\/10.1186\/s13012-016-0371-0.","DOI":"10.1186\/s13012-016-0371-0"},{"key":"564_CR85","doi-asserted-by":"crossref","unstructured":"MacKinnon, Kinnon R, et al. \u201cPatient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: qualitative process evaluation of the enhanced syphilis screening among HIV-positive men trial.\u201d 2020, doi:10.21203\/rs.3.rs-44050\/v1.","DOI":"10.21203\/rs.3.rs-44050\/v1"},{"key":"564_CR86","doi-asserted-by":"publisher","unstructured":"Tuite AR, et al. Cost-effectiveness of enhanced syphilis screening among HIV-positive men who have sex with men: a microsimulation model. PLoS ONE. 2014;9(7). https:\/\/doi.org\/10.1371\/journal.pone.0101240.","DOI":"10.1371\/journal.pone.0101240"},{"issue":"25","key":"564_CR87","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/nejm198706183162503","volume":"316","author":"DR Johns","year":"1987","unstructured":"Johns DR, et al. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. New England Journal of Medicine. 1987;316(25):1569\u201372. https:\/\/doi.org\/10.1056\/nejm198706183162503.","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"564_CR88","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1056\/nejm198706183162507","volume":"316","author":"CD Berry","year":"1987","unstructured":"Berry CD, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. New England Journal of Medicine. 1987;316(25):1587\u20139. https:\/\/doi.org\/10.1056\/nejm198706183162507.","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"564_CR89","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/infdis\/163.6.1201","volume":"163","author":"DM Musher","year":"1991","unstructured":"Musher DM. Syphilis, neurosyphilis, penicillin, and AIDS. Journal of Infectious Diseases. 1991;163(6):1201\u20136. https:\/\/doi.org\/10.1093\/infdis\/163.6.1201.","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"564_CR90","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/515245","volume":"177","author":"JM Flood","year":"1998","unstructured":"Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. Journal of Infectious Diseases. 1998;177(4):931\u201340. https:\/\/doi.org\/10.1086\/515245.","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"564_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/sextrans-2016-052938","volume":"94","author":"A Tomkins","year":"2017","unstructured":"Tomkins A, et al. Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study. Sexually Transmitted Infections. 2017;94(5):337\u20139. https:\/\/doi.org\/10.1136\/sextrans-2016-052938.","journal-title":"Sexually Transmitted Infections"},{"key":"564_CR92","doi-asserted-by":"publisher","unstructured":"Ghanem KG. Management of adult syphilis: key questions to inform the 2015 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines: Table 1. Clinical Infectious Diseases. 61(suppl 8):2015. https:\/\/doi.org\/10.1093\/cid\/civ714.","DOI":"10.1093\/cid\/civ714"},{"issue":"7","key":"564_CR93","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/591534","volume":"47","author":"CM Marra","year":"2008","unstructured":"Marra CM, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clinical Infectious Diseases. 2008;47(7):893\u20139. https:\/\/doi.org\/10.1086\/591534.","journal-title":"Clinical Infectious Diseases"},{"key":"564_CR94","doi-asserted-by":"publisher","unstructured":"Xiao Y, et al. Serological response predicts normalization of cerebrospinal fluid abnormalities at six months after treatment in HIV-negative neurosyphilis patients. Scientific Reports. 2017;7(1). https:\/\/doi.org\/10.1038\/s41598-017-10387-x.","DOI":"10.1038\/s41598-017-10387-x"},{"issue":"2","key":"564_CR95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/cid\/ciz795","volume":"71","author":"SB Dunaway","year":"2019","unstructured":"Dunaway SB, et al. Neurosyphilis treatment outcomes after intravenous penicillin G versus intramuscular procaine penicillin plus oral probenecid. Clinical Infectious Diseases. 2019;71(2):267\u201373. https:\/\/doi.org\/10.1093\/cid\/ciz795.","journal-title":"Clinical Infectious Diseases"},{"key":"564_CR96","doi-asserted-by":"publisher","unstructured":"Buitrago-Garcia D, et al. Antibiotic therapy for adults with neurosyphilis. Cochrane Database of Systematic Reviews. 2019. https:\/\/doi.org\/10.1002\/14651858.cd011399.pub2.","DOI":"10.1002\/14651858.cd011399.pub2"},{"key":"564_CR97","unstructured":"Klausner, Jeffery D., et al. Cefixime for alternative syphilis treatment. (n.d.) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03660488"},{"issue":"2","key":"564_CR98","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cid\/civ243","volume":"61","author":"LM Causer","year":"2015","unstructured":"Causer LM, et al. An evaluation of a novel dual treponemal\/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infection. Clinical Infectious Diseases. 2015;61(2):184\u201391. https:\/\/doi.org\/10.1093\/cid\/civ243.","journal-title":"Clinical Infectious Diseases"},{"key":"564_CR99","doi-asserted-by":"publisher","unstructured":"Zhou C, et al. PCR detection for syphilis diagnosis: status and prospects. Journal of Clinical Laboratory Analysis. 2019;33(5). https:\/\/doi.org\/10.1002\/jcla.22890.","DOI":"10.1002\/jcla.22890"},{"issue":"3","key":"564_CR100","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/jcm.00702-11","volume":"50","author":"PA Grange","year":"2012","unstructured":"Grange PA, Gressier L, Dion PL, Farhi D, Benhaddou N, Gerhardt P, et al. Evaluation of a PCR test for detection of Treponema Pallidum in swabs and blood. Journal of Clinical Microbiology. 2012;50(3):546\u201352. https:\/\/doi.org\/10.1128\/jcm.00702-11.","journal-title":"Journal of Clinical Microbiology"},{"key":"564_CR101","volume-title":"Conference on Retroviruses and Opportunistic Infections","author":"J-M Molina","year":"2017","unstructured":"Molina J-M, et al. On demand post exposure prophylaxis with doxycycline for MSM enrolled in a prep trial. In: Conference on Retroviruses and Opportunistic Infections. Washington: Seattle; 2017."},{"key":"564_CR102","unstructured":"Tattersall, Tessa Lawson, et al. \u201cPreliminary results of the Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) trial.\u201d The 29th Annual Canadian Conference on HIV\/AIDS Research, 2020."},{"issue":"2","key":"564_CR103","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/olq.0000000000000216","volume":"42","author":"RK Bolan","year":"2015","unstructured":"Bolan RK, et al. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex. Sexually Transmitted Diseases. 2015;42(2):98\u2013103. https:\/\/doi.org\/10.1097\/olq.0000000000000216.","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"564_CR104","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/qad.0b013e32834ed991","volume":"26","author":"R Steen","year":"2012","unstructured":"Steen R, et al. Periodic presumptive treatment of curable sexually transmitted infections among sex workers. AIDS. 2012;26(4):437\u201345. https:\/\/doi.org\/10.1097\/qad.0b013e32834ed991.","journal-title":"AIDS"},{"key":"564_CR105","doi-asserted-by":"publisher","unstructured":"Lithgow KV, et al. A defined syphilis vaccine candidate inhibits dissemination of Treponema Pallidum Subspecies Pallidum. Nature Communications. 2017;8(1). https:\/\/doi.org\/10.1038\/ncomms14273.","DOI":"10.1038\/ncomms14273"},{"key":"564_CR106","doi-asserted-by":"publisher","unstructured":"Tan DH, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. Canadian Medical Association Journal. 2017;189(47). https:\/\/doi.org\/10.1503\/cmaj.170494.","DOI":"10.1503\/cmaj.170494"},{"key":"564_CR107","unstructured":"Centre for Disease Control and Prevention, \u201cPreexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2017 Update A Clinical Practice Guideline\u201d, https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"564_CR108","doi-asserted-by":"publisher","unstructured":"Werner RN, et al. Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection \u2013 a meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLOS ONE. 2018;13(12). https:\/\/doi.org\/10.1371\/journal.pone.0208107.","DOI":"10.1371\/journal.pone.0208107"},{"key":"564_CR109","unstructured":"Sexual Health London. \u201cHome STI testing, regular and emergency contraception. 2021.\u201dhttps:\/\/www.shl.uk\/"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-021-00564-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-021-00564-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-021-00564-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:49:45Z","timestamp":1744152585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-021-00564-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,6]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s11904-021-00564-z","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,6]]},"assertion":[{"value":"18 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Melody Ren and Thomas Dashwood declare that they have no conflict of interest. Sharon Walmsley reports grants, personal fees, non-financial support, and other from Merck; grants, personal fees, non-financial support, and other from Gilead Sciences; grants, personal fees, non-financial support, and other from ViiV Healthcare; grants, personal fees, non-financial support, and other from GSK; and grants and personal fees from Janssen, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}